Søgning på udtrykket 'hiv' giver 139 resultater


Dokumenter [12] Sider [7] Kalender [76] Nyt fra tidsskrifterne [+20] Aktuelle smitsomme sygdomme [+20]

Dokumenter [12]

Forfattere: Jan Gerstoft, Nina Weis, Terese L. Katzenstein (Dansk Selskab for Infektionsmedicin), Anders Nyboe Andersen og Jens Fedder (Dansk Fertilitetsselskab).

Endelig guideline: 01.09.2020 Version: 3 Guideline skal revideres senest: 01.09.2023 Arbejdsgruppens medlemmer: Peer Brehm Christensen, Christian Erikstrup, Jan Gerstoft, Terese Katzenstein, Alex Laursen, Suzanne Lunding, Birgitte Mørn og Nina Weis.

Arbejdsgruppen bestod af: Jan Gerstoft, Ann-Brit Eg Hansen, Gitte Kronborg, Jens D. Lundgren, Henrik I. Nielsen, Olav Ditlevsen Larsen, Niels Obel og Alex Laursen

Fællesregional retningslinje for udlevering af forebyggende medicin mod HIV (PrEP), udgivet af Danske Regioner.

Europæisk guideline om hvornår, der bør testes for HIV. Udgivet af "HIV in Europe", et paneuropæisk initiativ for tidligere diagnosticering og behandling af HIV.

Anbefaling for profylakse og opfølgning af stikuheld og anden blodeksposition. Arbejdsgruppe: Suzanne Lunding (formand), Peer Brehm Christensen, Christian Erikstrup, Terese L. Katzenstein, Henrik Krarup, Alex Lund Laursen, Birgitte Mørn og Nina Weis

Senest revideret september 2021 . Arbejdsgruppen bestod af: Jan Gerstoft, Gitte Kronborg , Ann Brit Eg Hansen, Jens D. Lundgren, Henrik I. Nielsen, Olav Ditlevsen Larsen , Niels Obel og Alex Laursen

Arrangeret af Yngre Infektionsmedicinere

I forbindelse med Sundhedsstyrelsens udgivelse af "Personer med øget risiko ved COVID-19. Fagligt grundlag", har DSI beskrevet følgende specialespecifikke patienter med øget risiko for et alvorligt COVID-19 sygdomsforløb.

Sider [7]

Formål: At kursisten skal opnå en forståelse af HIV-infektionen herunder viden om dens epidemiologi, patogenese, patofysiologi, diagnose, forebyggelse, behandlingsmuligheder og prognose samt viden om diagnostik og behandlingen af AIDS-definerende sygdomme og de hyppigste sexuelt overførte sygdomme. Tid og sted: Hvidovre Hospital. Lokale 10 i undervisningsbygningen. Delkursusledere: Ann-Brit Eg Hansen og Ole Kirk. Program: Mandag 3. oktober: 10:00-10:15 Velkomst og introduktion (Ann-…

…me og biologisk terrorisme. Specialet er karakteriseret ved et sygdomspanorama hvor sygdommenes prævalens såvel som incidens ændres hurtigt på lokalt og globalt plan. Over de seneste tyve år har specialet udviklet sig til at håndtere behandlingen af HIV og AIDS. I de seneste år er nye alvorlige infektionssygdomme som SARS, fugleinfluenza, West Nile virus, Hanta virus, Nipah virus, og Hendra virus tilkommet. Alvorlige sygdomme som hæmoragisk viral feber forårsaget af Ebola, Lassa, Dengue, Crimean-Co…

…æsentanter i diverse arbejdsgrupper og udvalg, og publicerede guidelines. Antiretroviral terapi: Henrik Nielsen, Jan Gerstoft, Jens Lundgren, Alex Laursen, Niels Obel, Olav Larsen, Gitte Kronborg, Ann-Brit Eg Hansen Antiviral behandling af hiv smittede personer, Fertilitetsbehandling ved HIV og hepatitis B og C, HIV behandling af gravide, HIV post exposure profylakse (PEP), Pre-exposure profylakse mod HIV (PrEP), Borrelia: Anne-Mette Lebech, Sigurdur Skarphedinsson …

…eptember 2021 Gastroenterologiske infektioner og kronisk hepatitis: Dato for næste kursus Efterår 2023: Sted Hvidovre Hospital Delkursusledelse Morten Helms. Peer Brehm Christensen  Tidligere kurser 3. og 4. december 2020 HIV-infektion: Dato for næste kursus 12. og 13. oktober 2022 (2 dage): Sted Endnu ikke afklaret Delkursusledelse Ole Schmeltz Søgaard og Lene Ryom Nielsen  Tidligere kurser 7. og 8. oktober 2019 3. og 4. oktober 2016 Immundefekt og…

…me og biologisk terrorisme. Specialet er karakteriseret ved et sygdomspanorama hvor sygdommenes prævalens såvel som incidens ændres hurtigt på lokalt og globalt plan. Over de seneste tyve år har specialet udviklet sig til at håndtere behandlingen af HIV og AIDS. I de seneste år er nye alvorlige infektionssygdomme som SARS, fugleinfluenza, West Nile virus, Hanta virus, Nipah virus, og Hendra virus tilkommet. Alvorlige sygdomme som hæmoragisk viral feber forårsaget af Ebola, Lassa, Dengue, Crimean-Co…

Formål: Rejsefondens formål er at yde økonomisk støtte til lægelige medlemmer af DSI med henblik på deltagelse på følgende kongresser: NSCMID, ECCMID, IDWeek, HIV og Hepatitis Nordic Conference, EACS/Glasgow HIV og CROI. Hvad kan der søges om? Der kan søges om økonomisk støtte til registreringsafgift, rejseudgifter og indlogering til de respektive kongresser. Det er ikke et krav at man har et videnskabeligt bidrag på kongressen. Man kan højest få tildelt støtte til én kongres årligt. …


Kalender [76]

23. oktober, Glasgow, Skotland
20. oktober, Washington DC, USA
28. september, Stockholm, Sverige
17. maj, Niels K. Jerne auditoriet, Panum Instituttet, København
6. december 2021, Rigshospitalet
26. november 2021, Panum, København
30. september 2021, Barcelona, Spanien
23. marts 2021, Online
28. oktober 2020, Paris, Frankrig
25. oktober 2020, Glasgow, Skotland
28. august 2020, Online og Henrik Dam auditoriet, Maersk Tårnet
10. marts 2020, KolleKolle, Værløse
7. oktober 2019, København
11. september 2019, DGI-byen, København
22. maj 2019, Rom, Italien
13. maj 2019, København, Odense, Aarhus
6. marts 2019, KolleKolle, Værløse
2. november 2018, Mærsk Tower, København
28. oktober 2018, Glasgow, Skotland
30. maj 2018, Rom, Italien
4. maj 2018, Hindsgavl, Middelfart
16. marts 2018, Værløse
28. februar 2018, Nielsine Nielsen Auditorium, Mærsk Tårnet, København
23. februar 2018, Syddansk Universitet, Odense
1. februar 2018, Nielsine Nielsen auditoriet, Mærsk Tårnet, København
6. oktober 2017, Holst Auditoriet, Mærsk tårnet, København
8. juni 2017, Hvidovre Hospital
4. maj 2017, Odense Universitetshospital
18. april 2017, Auditorium 93, Rigshospitalet
23. oktober 2016, Glasgow, Skotland
3. oktober 2016, Hvidovre Hospital
25. maj 2016, Rom, Italien
29. april 2016, Hindsgavl, Middelfart
7. januar 2016, Medicinsk Museion, København
18. december 2015, Emil Aarestrup auditorium, Odense Universitetshospital
24. november 2015, Hvidovre Universitetshospital
8. september 2015, Panum Instituttet, København
18. juni 2015, Rigshospitalet, Teilum B
12. juni 2015, Medicinsk Museion, København
3. juni 2015, Barcelona, Spanien
24. april 2015, Auditorium 93, Rigshospitalet
17. april 2015, Foredragssalen, Statens Serum Institut
19. marts 2015, Auditorium 1, Rigshospitalet
2. november 2014, Glasgow, Skotland
5. oktober 2014, Barcelona, Spanien
18. juni 2014, Store Auditorium, Winsløwparken 15, st., 5000 Odense C
22. april 2014, Auditorium 5, Hvidovre Hospital
26. marts 2014, Barcelona, Spanien
25. oktober 2013, Hannover auditoriet, Panum Instituttet, København
30. juni 2013, Kuala Lumpur, Malaysia
10. juni 2013, Centre for Medical Parasitology, København
3. maj 2013, Hindsgavl, Fyn
20. marts 2013, Rom, Italien
14. januar 2013, Auditorium 2, Rigshospitalet
10. november 2012, Auditorium 2, Rigshospitalet
25. oktober 2012, Danmarks Medie- og Journalisthøjskole
23. oktober 2012, Rigshospitalet
2. oktober 2013, San Francisco, USA
27. september 2012, Auditorium 1, Bartholinbygningen, bygning 1241, lokale 135, Aarhus Universitet
29. februar 2012, SSI, København
9. december 2011, Rigshospitalet, københavn
7. november 2011, Auditorium 93, Rigshospitalet
13. maj 2011, Panum instituttet, København
29. april 2011, Auditorium B, Skejby
12. april 2011, Auditorium 100, Campusvej 55, 5230 Odense M, Syddansk Universitet
30. november 2007, Panum Instituttet, København

Nyt fra tidsskrifterne [+20]

Der er mere end 20 resultater, måske du vil se flere resultater her?
BMC Infectious Diseases
16.05.2022
… The child was a 5-year-old girl with persistent cough and gasping over 2 months who was confirmed with T. marneffei infection by bronchoalveolar lavage fluid culture and high-throughput sequencing technology. Human immunodeficiency virus (HIV) was negative according to a serum-specific antibody test. She was treated with amphotericin B and itraconazole as antifungal agents, with good clinical response. At follow-up, high-resolution computed tomography showed a mosaic sign in the whole lung …
BMC Infectious Diseases
16.05.2022
. Abstract. . Background. Symptoms of depression are prevalent in people living with human immune deficiency virus/acquired immune deficiency syndrome (PLWHA), and worsened by lack of physical activity/exercises, leading to restriction in social participation/functioning. This raises the question: what is the extent to which physical exercise training affected, symptoms of depression, physical activity level (PAL) and so…
BMC Infectious Diseases
16.05.2022
… Vaccination has been proven to be an effective approach against the coronavirus disease 2019 (COVID-19) pandemic. This study aimed to determine the acceptance rate and factors influencing acceptance of COVID-19 vaccination among people living with HIV (PLWH) in Guangxi, China. . . Methods. A cross-sectional survey was carried out in five cities in Guangxi, China from May 7 to June 1, 2021. Questionnaires on the a…
PLoS One Infectious Diseases
13.05.2022
by Frank H. Galvan, Honghu Liu, Ronald A. Brooks, Ying-Tung Chen, Ricardo Mendoza Lepe. . HIV disproportionately affects Latinos versus Whites, with Latinos having higher rates of HIV. Additionally, many HIV-positive Latinos are unaware of their infection. Proyecto Protégete, an HIV prevention intervention developed for Latino men who have sex with men (MSM), used social and sexual networking mobile applications (apps) to recruit individuals for HIV testing and linkage to medical care and prevention serv…
BMJ Open
13.05.2022
. Introduction. Human immunodeficiency virus (HIV) prevention interventions focused at reducing risky sexual behaviours are an important strategy for preventing HIV infection among youth (15–24 years) who continue to be vulnerable to the disease. This systematic review aims to synthesise current global evidence on the effectiveness of HIV prevention interventions for reducing risky sexual behaviour among youth in the last decade. . Methods and analysis. MEDLINE/PubMed, EMBASE, PsychINFO, ProQuest…
Nature
12.05.2022
Nature Medicine, Published online: 12 May 2022; doi:10.1038/s41591-022-01815-1. A combination of three monoclonal antibodies transiently reduced viremia in people living with HIV-1 and not on antiretroviral therapy, but it did not prevent viral rebound. Further studies are needed to determine if this approach can be optimized.
BMJ Open
11.05.2022
. Objective. To conduct a systematic review and meta-analysis of randomised controlled trials (RCTs) of the effectiveness and safety of oral pre-exposure prophylaxis (PrEP) to prevent HIV. . Methods. Databases (PubMed, Embase and the Cochrane Register of Controlled Trials) were searched up to 5 July 2020. Search terms for ‘HIV’ were combined with terms for ‘PrEP’ or ‘tenofovir/emtricitabine’. RCTs were included that compared oral tenofovir-containing PrEP to placebo,…
PLoS One Infectious Diseases
11.05.2022
…) case definition criteria for Meningitis. All samples were tested by cryptococcal antigen (CrAg) lateral flow assay (LFA), culture and triplex real-time polymerase chain reaction (qPCR) assay and all patients were tested for human immunodeficiency virus (HIV) using the national algorithm for HIV testing. Results Retrospective analysis of 1501 CSF samples from adults clinically suspected of meningitis revealed that 10.5% (158/1501) were positive for bacterial and fungal meningitis. Of these 158 confirmed c…
New England Journal of Medicine
11.05.2022
New England Journal of Medicine, Volume 386, Issue 19, Page 1848-1849, May 2022.
New England Journal of Medicine
11.05.2022
New England Journal of Medicine, Volume 386, Issue 19, Page 1793-1803, May 2022.
BMC Infectious Diseases
11.05.2022
… Abstract. . Background. Monocytes play an important role in inflammation, and monocytosis and monocyte activation are features of chronic inflammation. We aimed to investigate if HIV status was associated with monocyte count and monocyte activation and to assess the relationship between monocyte count and monocyte activation markers and HIV-related factors. . . Method…
BMC Infectious Diseases
11.05.2022
. Abstract. . Background. In sub-Saharan Africa, data on virologic outcomes of young people living with HIV (YLWH) enrolled on antiretroviral therapy (ART) remains scarce. In this study, we describe the prevalence of HIV virological non-suppression (VNS) and its associated factors among YLWH aged 18–24 years from the Kenyan coast. . . Methods. …
BMC Infectious Diseases
11.05.2022
… Abstract. . Background. Monocytes play an important role in inflammation, and monocytosis and monocyte activation are features of chronic inflammation. We aimed to investigate if HIV status was associated with monocyte count and monocyte activation and to assess the relationship between monocyte count and monocyte activation markers and HIV-related factors. . . Method…
BMC Infectious Diseases
11.05.2022
. Abstract. . Background. In sub-Saharan Africa, data on virologic outcomes of young people living with HIV (YLWH) enrolled on antiretroviral therapy (ART) remains scarce. In this study, we describe the prevalence of HIV virological non-suppression (VNS) and its associated factors among YLWH aged 18–24 years from the Kenyan coast. . . Methods. …
BMJ Open
10.05.2022
. Introduction. The large number of key populations in China who would benefit from HIV pre-exposure prophylaxis (PrEP) in the context of limited health system capacity and public awareness will pose challenges for timely PrEP scale-up, suggesting an urgent need for innovative and accessible interventions. This study aims to develop and pilot test a theory-informed, tailored mobile phone intervention that was codeveloped by young gay men, HIV clinicians and public health researchers to increase engagement…
BMC Infectious Diseases
10.05.2022
. Abstract. . Introduction. In Mexico, HIV genotyping is performed in people living with HIV (PLWH) failing their first-line antiretroviral (ARV) regimen; it is not routinely done for all treatment-naive PLWH before ARV initiation. The first nationally representative survey published in 2016 reported that the prevalence of pretreatment drug mutations in treatment-naive Mexican PLWH was 15.5% to any antiretroviral drug a…
International Journal of Infectious Diseases
10.05.2022
: In resource-limited settings, intestinal Cryptosporidia or coccidian infections are common causes of chronic diarrhoea, but usually remain undiagnosed by routine stool investigation. Here, the addition of the Kinyoun staining technique after stool concentration was evaluated as an easy and inexpensive method for diagnosis of intestinal parasitic infection in HIV-infected patients.
BMC Infectious Diseases
10.05.2022
. Abstract. . Introduction. In Mexico, HIV genotyping is performed in people living with HIV (PLWH) failing their first-line antiretroviral (ARV) regimen; it is not routinely done for all treatment-naive PLWH before ARV initiation. The first nationally representative survey published in 2016 reported that the prevalence of pretreatment drug mutations in treatment-naive Mexican PLWH was 15.5% to any antiretroviral drug a…
BMJ Open
6.05.2022
. Introduction. Sub-Saharan Africa (SSA) is faced with the dual epidemics of HIV/AIDS and non-communicable diseases (NCDs). Cardiovascular diseases, cancers, chronic respiratory diseases, diabetes and mental illnesses are the five major NCDs, causing death globally with low-income and middle-income countries, contributing 78% of all NCD deaths and 85% of premature deaths. There has been increased interest in the integration of HIV and NCDs care, especially in SSA that accounts for 55% of people living wit…

Aktuelle smitsomme sygdomme [+20]

Der er mere end 20 resultater, måske du vil se flere resultater her?
Medscape Infectious Diseases
11.04.2022
A sophisticated criminal enterprise has been operating at scale to distribute and profit from counterfeit HIV drugs. The details read like a best-selling crime novel. .
Medscape Infectious Diseases
11.04.2022
Advocates say it's one of the strongest rulings in years for people living with HIV. .
Eurosurveillance latest updates
7.04.2022
. Introduction. Users of pre-exposure prophylaxis (PrEP) require periodic testing for HIV, sexually transmitted infections (STI) and renal function. Before PrEP was made free of charge through statutory health insurance in late 2019, PrEP users in Germany had to pay for testing themselves. . . Aim. We investigated self-reported HIV, STI and renal function testing frequencies among self-funded PrEP users in Germany, factors associated with infrequent testing, and STI diagnoses. . . Methods. A cross…
Eurosurveillance latest updates
7.04.2022
. Introduction. Despite increased use of pre-exposure prophylaxis (PrEP) in Germany, HIV infection rates are not declining and little is known about how this prevention method affects the prevalence of sexually transmitted infections (STI) among men who have sex with men (MSM). . . Aim. We studied, in a large multicentre cohort, STI point prevalence, co-infection rates, anatomical location and influence of PrEP. . . Methods. The BRAHMS study was a prospective cohort study conducted at 10 sites in …
Eurosurveillance latest updates
7.04.2022
In August 2021, a man who has sex with men was diagnosed with HIV-1 infection despite using event-driven pre-exposure prophylaxis for over 2 years with self-reported excellent adherence. Sequencing identified resistance-associated mutations (RAM) M184V and K65R, conferring resistance to emtricitabine and tenofovir, and RAM V108I and E138A. Background RAM prevalence was two of 164 (1.2%) new HIV diagnoses in Amsterdam (2017–19). We reiterate the need for frequent HIV testing among PrEP users and additi…
Morbidity and Mortality Weekly Report (MMWR)
24.03.2022
This report describes programmatic gains of HIV treatment during the pandemic.
Medscape Infectious Diseases
10.03.2022
The big-data era has arrived in HIV epidemiology, allowing researchers to better track viruses through communities and the effect of those viruses in communities. .
Medscape Infectious Diseases
3.03.2022
The rules were issued clarifying that health plans need to cover the costs of prescription drugs to prevent HIV infection, lab tests, and medical appointments, at no cost. The erroneous billing continues. .
Morbidity and Mortality Weekly Report (MMWR)
3.03.2022
This report describes an analysis of HIV infection data collected during surveillance in Malawi.
Medscape Infectious Diseases
16.02.2022
A third person who has been 'cured' of HIV through a unique transplant of stem cells has given hope for a larger-scale way to beat back the HIV epidemic that has plagued the world for four decades. .
Medscape Infectious Diseases
16.02.2022
Since the Mississippi baby captured the imagination of scientists, researchers have been looking for a way to replicate that treatment-free remission. Should preemptive HIV ART apply to infants too? .
Morbidity and Mortality Weekly Report (MMWR)
3.02.2022
This report describes COVID-19 vaccination coverage among adults diagnosed with HIV infection.
Morbidity and Mortality Weekly Report (MMWR)
3.02.2022
This report describes social vulnerability and rates of HIV diagnoses among black adults.
Medscape Infectious Diseases
25.01.2022
One year after the World Health Organization recommended a vaginal ring to protect women from HIV following years of research — some done in the US — the ring will not be coming to US clinics. Here's why. .
Medscape Infectious Diseases
18.01.2022
Gilead Sciences said on Tuesday that tampered and counterfeit versions of its HIV treatments worth $250 million were sold to pharmacies over 2 years by a network of drug distributors and suppliers. .
Morbidity and Mortality Weekly Report (MMWR)
13.01.2022
This report describes a Kanawha County HIV outbreak during the COVID-19 pandemic among people who inject drugs.
Morbidity and Mortality Weekly Report (MMWR)
13.01.2022
This report describes HIV prevalence among young women in Lesotho.
Medscape Infectious Diseases
12.01.2022
Now that medical science has solved the HIV treatment paradigm, it might be time to shift to patient experience to end the AIDS epidemics. .
Medscape Infectious Diseases
5.01.2022
Patient and graft survival outcomes after 15 years support transplant benefits in HIV population. .
Medscape Infectious Diseases
27.12.2021
The first study of its kind shows regional global disparities in COVID-19 vaccination rates among people with HIV, who are at higher risk for COVID-19 mortality. .

Nyhedsbrev

Skriv din email adresse og modtag nyheder om hjemmesiden.


© 2022 Dansk Selskab for Infektionsmedicin

CVR: 33634307

version: 2.11.0 ● design: Christian Philip Fischer

Side indlæst på 0,975 s

Cookies og privatliv